Blenrep combination offers improved survival for those ineligible for lenalidomide
Category: News
Dutch biotech’s ORE-001 shows strong potential to prevent ileus after major surgery
New MHRA–FDA collaboration aims to boost patient access and AI safety
Positive safety and pharmacokinetic data lay foundation for phase 2 study in 2026
New survey reveals critical gaps in access to testing and timely care
Six new treatments aim to improve patient outcomes across key areas
UPSIDE study explores early transplant therapy for rare autoimmune disease
Early-stage study reveals strong immune response and safety profile for ACI-35.030
EU phase 3 data shows major gains in dialysis access performance
Acella and Neuvosyn report positive results for investigational DTE therapy